CAMP4 Therapeutics Corporation Temporary Equity, Liquidation Preference
CAMP4 Therapeutics Corporation (CAMP) had Temporary Equity, Liquidation Preference of $0 as of 2024-12-31, per its 10-K filed 2025-03-27.
Financial Statements › Balance Sheet › Equity › Temporary Equity › Temporary Equity, Other Disclosure
us-gaap:TemporaryEquityLiquidationPreference · last filed 2025-03-27
- 2024-12-31: Temporary Equity, Liquidation Preference $0.00.
- 2024-09-30: Temporary Equity, Liquidation Preference $162.88M.
- 2023-12-31: Temporary Equity, Liquidation Preference $162.88M.
| Period end | Temporary Equity, Liquidation Preference |
|---|---|
| 2024-12-31 | $0.00 10-K · filed 2025-03-27 |
| 2024-09-30 | $162.88M 10-Q · filed 2024-11-21 |
| 2023-12-31 | $162.88M 10-K · filed 2025-03-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |